BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30682644)

  • 1. Engineered bone for probing organotypic growth and therapy response of prostate cancer tumoroids in vitro.
    Paindelli C; Navone N; Logothetis CJ; Friedl P; Dondossola E
    Biomaterials; 2019 Mar; 197():296-304. PubMed ID: 30682644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures.
    Mosaad E; Chambers K; Futrega K; Clements J; Doran MR
    BMC Cancer; 2018 May; 18(1):592. PubMed ID: 29793440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
    Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
    Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening.
    Antunes J; Gaspar VM; Ferreira L; Monteiro M; Henrique R; Jerónimo C; Mano JF
    Acta Biomater; 2019 Aug; 94():392-409. PubMed ID: 31200118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery.
    Fontana F; Raimondi M; Marzagalli M; Sommariva M; Gagliano N; Limonta P
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule BKM1972 inhibits human prostate cancer growth and overcomes docetaxel resistance in intraosseous models.
    Chen Y; Gera L; Zhang S; Li X; Yang Y; Mamouni K; Wu AY; Liu H; Kucuk O; Wu D
    Cancer Lett; 2019 Apr; 446():62-72. PubMed ID: 30660650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.
    Shigemura K; Arbiser JL; Sun SY; Zayzafoon M; Johnstone PA; Fujisawa M; Gotoh A; Weksler B; Zhau HE; Chung LW
    Cancer; 2007 Apr; 109(7):1279-89. PubMed ID: 17326044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential culture on biomimetic nanoclay scaffolds forms three-dimensional tumoroids.
    Katti KS; Molla MS; Karandish F; Haldar MK; Mallik S; Katti DR
    J Biomed Mater Res A; 2016 Jul; 104(7):1591-602. PubMed ID: 26873510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-Time and 3D Quantification of Cancer Cell Dynamics: Exploiting a Bioengineered Human Bone Metastatic Microtissue.
    Bock N; Röhl J
    Methods Mol Biol; 2019; 2054():59-77. PubMed ID: 31482447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Assay of 2D and 3D Cell Culture Models: Proliferation, Gene Expression and Anticancer Drug Response.
    Souza AG; Silva IBB; Campos-Fernandez E; Barcelos LS; Souza JB; Marangoni K; Goulart LR; Alonso-Goulart V
    Curr Pharm Des; 2018; 24(15):1689-1694. PubMed ID: 29623827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic effects of probenecid on three-dimensional cultures of prostate cancer cells.
    Uwada J; Mukai S; Terada N; Nakazawa H; Islam MS; Nagai T; Fujii M; Yamasaki K; Taniguchi T; Kamoto T; Yazawa T
    Life Sci; 2021 Aug; 278():119554. PubMed ID: 33932444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic Mechanisms Drive Endocrine Resistance in the Three-Dimensional Bone Microenvironment.
    Dhimolea E; de Matos Simoes R; Kansara D; Weng X; Sharma S; Awate P; Liu Z; Gao D; Mitsiades N; Schwab JH; Chen Y; Jeselsohn R; Culhane AC; Brown M; Georgakoudi I; Mitsiades CS
    Cancer Res; 2021 Jan; 81(2):371-383. PubMed ID: 32859606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of a Histone Deacetylase Inhibitor (AR-42) on Canine Prostate Cancer Growth and Metastasis.
    Elshafae SM; Kohart NA; Altstadt LA; Dirksen WP; Rosol TJ
    Prostate; 2017 May; 77(7):776-793. PubMed ID: 28181686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone.
    Liang W; Wang F; Chen Q; Dai J; Escara-Wilke J; Keller ET; Zimmermann J; Hong N; Lu Y; Zhang J
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):1999-2012. PubMed ID: 31172267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor spheroid-based migration assays for evaluation of therapeutic agents.
    Vinci M; Box C; Zimmermann M; Eccles SA
    Methods Mol Biol; 2013; 986():253-66. PubMed ID: 23436417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions.
    Wenzel C; Riefke B; Gründemann S; Krebs A; Christian S; Prinz F; Osterland M; Golfier S; Räse S; Ansari N; Esner M; Bickle M; Pampaloni F; Mattheyer C; Stelzer EH; Parczyk K; Prechtl S; Steigemann P
    Exp Cell Res; 2014 Apr; 323(1):131-143. PubMed ID: 24480576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Microwell-mesh: A high-throughput 3D prostate cancer spheroid and drug-testing platform.
    Mosaad EO; Chambers KF; Futrega K; Clements JA; Doran MR
    Sci Rep; 2018 Jan; 8(1):253. PubMed ID: 29321576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
    Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
    Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
    Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
    Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemo-sensitivity of Two-dimensional Monolayer and Three-dimensional Spheroid of Breast Cancer MCF-7 Cells to Daunorubicin, Docetaxel, and Arsenic Disulfide.
    Uematsu N; Zhao Y; Kiyomi A; Yuan BO; Onda K; Tanaka S; Sugiyama K; Sugiura M; Takagi N; Hayakawa A; Hirano T
    Anticancer Res; 2018 Apr; 38(4):2101-2108. PubMed ID: 29599328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.